Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Denis O'Shaughnessy"'
Autor:
Mark Moster, Raymond Douglas, Kimberly Cockerham, Roger Turbin, Navdeep Nijhawan, Jade Schiffman, Shoaib Ugradar, Denis O’Shaughnessy, Rochelle Summerfelt, Angela She, Barrett Katz
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::147a1fe01fb74bae5055ae78589235a3
https://doi.org/10.1212/wnl.0000000000202314
https://doi.org/10.1212/wnl.0000000000202314
Autor:
Jeffrey S. Heier, Philip J. Rosenfeld, Jennifer Cerami, Carl C. Awh, Kate Fisher, Denis O'Shaughnessy, Michael N. Cohen, Daniel E Salazar
Publikováno v:
British Journal of Ophthalmology. 105:716-722
PurposeThe safety and efficacy of X-82, an orally administered inhibitor of vascular endothelial growth factor (VEGF) and platelet-derived growth factor, was investigated for treatment of wet age-related macular degeneration (AMD) in a phase II clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a7674f9ef3ceba8b491d295fce86e7f
https://doi.org/10.1136/bjophthalmol-2020-316511
https://doi.org/10.1136/bjophthalmol-2020-316511
Autor:
Lise Plaine, Catherine Vignal-Clermont, Jean-François Girmens, Saddek Mohand Said, Marie-Hélène Errera, Magali Taiel, Denis O’Shaughnessy, José-Alain Sahel, Isabelle Audo
Publikováno v:
BioDrugs
BioDrugs, Adis, 2021, ⟨10.1007/s40259-021-00468-9⟩
Biodrugs
BioDrugs, 2021, ⟨10.1007/s40259-021-00468-9⟩
BioDrugs, Adis, 2021, ⟨10.1007/s40259-021-00468-9⟩
Biodrugs
BioDrugs, 2021, ⟨10.1007/s40259-021-00468-9⟩
Background Leber hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disease whose primary clinical manifestation is bilateral visual loss. Only a single therapy, idebenone, is approved in Europe for use in exceptional circumst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c0234d0ad91a512eef532999dc76ad3
https://hal.sorbonne-universite.fr/hal-03139112/document
https://hal.sorbonne-universite.fr/hal-03139112/document
Autor:
Denis O'Shaughnessy, Florentina J. Freiberg, Linda Danielson, Usha Chakravarthy, Stephan Michels, Jason S. Slakter, Alyson Muldrew, Alan Czeszynski, Timothy L Jackson
Publikováno v:
Freiberg, F J, Michels, S, Muldrew, A, Slakter, J, O'Shaughnessy, D, Czeszynski, A, Danielson, L, Jackson, T L & Chakravarthy, U 2018, ' Microvascular abnormalities secondary to radiation therapy in neovascular age-related macular degeneration : Findings from the INTREPID clinical trial ', The British journal of ophthalmology . https://doi.org/10.1136/bjophthalmol-2018-311865
PurposeTo report the incidence and features of retinal microvascular abnormalities (MVAs) occurring secondary to stereotactic radiotherapy (SRT) in a randomised double-masked sham-controlled clinical trial at 21 European sites.MethodsTwo hundred and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de80e53ba09891f41b60336ed08203e6
https://doi.org/10.1136/bjophthalmol-2018-311865
https://doi.org/10.1136/bjophthalmol-2018-311865
Autor:
Michael J. Elman, Chris Liang, David S. Boyer, Philip J. Rosenfeld, Nauman A Chaudhry, E. C. M. Parsons, Sunil S. Patel, Denis O'Shaughnessy, Timothy L Jackson, Jason S. Slakter, David M. Brown
Publikováno v:
JAMA ophthalmology. 135(7)
Importance An oral treatment for neovascular age-related macular degeneration would be less burdensome than repeated intravitreous injections. X-82 is an oral tyrosine kinase inhibitor active against vascular endothelial growth factor (VEGF) and plat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e648fbecd5c6ba27e9fb3644bcace872
https://pubmed.ncbi.nlm.nih.gov/31046112
https://pubmed.ncbi.nlm.nih.gov/31046112
Autor:
Usha Chakravarthy, Ugo Introini, Giuseppe Casalino, E. Mark Shusterman, Giacinto Triolo, Denis O'Shaughnessy, Francesco Bandello, Jason S. Slakter
Publikováno v:
Ophthalmologica. 233:82-88
Purpose: To evaluate low-voltage X-ray stereotactic radiotherapy (SRT) delivered in conjunction with intravitreal ranibizumab for the treatment of active macular polypoidal choroidal vasculopathy (PCV). Methods: At baseline, all eyes received an intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e10ca64909ad92d43d13d62d542e6c9
https://doi.org/10.1159/000368561
https://doi.org/10.1159/000368561
Autor:
Timothy L Jackson, Michael Gertner, Jason S. Slakter, Mark Arnoldussen, Denis O'Shaughnessy, Linda Danielson, E. Mark Shusterman, Darius M. Moshfeghi, Alyson Muldrew, Usha Chakravarthy
Publikováno v:
Ophthalmology. 120:1893-1900
Purpose To determine the safety and efficacy of low-voltage, external-beam, stereotactic radiotherapy (SRT) for patients with neovascular age-related macular degeneration (nvAMD). Design Randomized, double-masked, sham-controlled, multicenter, clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6087eb6c5accebda70ad889d33691e8b
https://doi.org/10.1016/j.ophtha.2013.02.016
https://doi.org/10.1016/j.ophtha.2013.02.016
Autor:
Timothy L, Jackson, Usha, Chakravarthy, Jason S, Slakter, Alyson, Muldrew, E Mark, Shusterman, Denis, O'Shaughnessy, Mark, Arnoldussen, Michael E, Gertner, Linda, Danielson, Darius M, Moshfeghi, Yit, Yang
Publikováno v:
Ophthalmology. 122(1)
To determine the safety and efficacy of low-voltage, external-beam, stereotactic radiotherapy (SRT) for patients with neovascular age-related macular degeneration (AMD).Randomized, double-masked, sham-controlled, multicenter, clinical trial.A total o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eeefbe77645d761d5a6bf5ba5023d876
https://pubmed.ncbi.nlm.nih.gov/25208859
https://pubmed.ncbi.nlm.nih.gov/25208859
Autor:
Timothy L, Jackson, Usha, Chakravarthy, Peter K, Kaiser, Jason S, Slakter, Ernest, Jan, Francesco, Bandello, Denis, O'Shaughnessy, Michael E, Gertner, Linda, Danielson, Darius M, Moshfeghi, Yit, Yang
Publikováno v:
Ophthalmology. 120(9)
To determine the safety and efficacy of low-voltage, external-beam, stereotactic radiotherapy (SRT) for patients with neovascular age-related macular degeneration (nvAMD).Randomized, double-masked, sham-controlled, multicenter, clinical trial.Two hun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e38b0844cc346fedaf6d7e952935d31
https://pubmed.ncbi.nlm.nih.gov/23490327
https://pubmed.ncbi.nlm.nih.gov/23490327
Autor:
David R. Guyer, Marlene W.. Modi, Denis O'Shaughnessy, Evelyn M. Harrison, Emmett T. Cunningham, Loni da Silva
Publikováno v:
Archives of ophthalmology (Chicago, Ill. : 1960). 122(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bba1ec6b8a1274fa1d4196ed9dc28b3
https://pubmed.ncbi.nlm.nih.gov/15249371
https://pubmed.ncbi.nlm.nih.gov/15249371